MedPath

Comparison of Continuous Femoral Nerve Block and Adductor Canal Block After Total Knee Replacement Therapy

Not Applicable
Completed
Conditions
Total Knee Arthroplasty
Total Knee Replacement
Adductor Canal Block
Femoral Nerve Block
Interventions
Registration Number
NCT02125903
Lead Sponsor
Philipps University Marburg Medical Center
Brief Summary

The blockade of the femoral nerve (FNB) is the most common postoperative pain therapy after total knee replacement. Because of motor-driven weakness of the quadriceps muscle induced by femoral nerve block mobilization of Patients is difficult even dangerous (falls) and hospital stays are extended.

An alternative method could be an adductor canal block (ACB). Anatomical studies of the adductor canal demonstrated that the adductor canal contains the saphenous nerve, a pure sensory nerve for medial and anterior aspects of the knee and the tibia without any motor function.

This prospective, double-blinded, randomized study investigates the effect of FNB and ACB on quadriceps motor weakness and analgesia determined by Numeric Rating Scale (NRS).

We expect the ACB to be superior in muscle strength but equal in pain score. Both groups receive an additional anterior sciatic nerve block for complete sensory block of the operated knee

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
44
Inclusion Criteria
  • patients with knee replacement therapy and general anaesthesia
  • informed consent
  • preoperative "timed up and go" test performable
Exclusion Criteria
  • emergency patients
  • BMI > 40 kg/m2
  • American Society of Anaesthesiologists physical status (ASA) 4-5
  • severe chronic obstructive pulmonary disease (COPD)
  • rheumatic arthritis, diabetic Polyneuropathy, M. Parkinson
  • nerve injury of lumbosacral plexus
  • coagulopathy with bleeding tendency
  • not capable of speaking or understanding german or english

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Continuous Adductor Canal Block (CACB)RopivacaineContinuous Adductor Canal block performed with: loading dose 0,375% Ropivacaine 15ml (56,25mg) start infusion 0,2% Ropivacaine 6ml/h Procedure: Femoral Nerve Block. Adductor Canal Block Drug: Ropivacaine
Continuous Femoral Nerve Block (CFNB)RopivacaineContinuous Femoral Nerve Block performed with: loading dose 0,375% Ropivacaine 15ml (56,25mg) start infusion 0,2% Ropivacaine 6ml/h Procedure: Femoral Nerve Block. Adductor Canal Block Drug: Ropivacaine
Primary Outcome Measures
NameTimeMethod
Timed-Up and Go-test for mobility evaluationthird postoperative day

The patient is observed and timed while he rises from an arm chair, walks 3 meters, turns, walks back, and sits down again.

Secondary Outcome Measures
NameTimeMethod
Quadriceps strength6, 24, 28, 72 hours postoperative

Numeric Scale (0-5)

Pain Scores6, 24, 48, 72 hours postoperative

Numeric Rating Scale (NRS), 0-10 for Rest / Stress. in Addition total Body NRS Pain

Ropivacaine consumption (each catheter)24, 48, 72 hours postoperative

Measurement of the total amount

Mobility Score (MoSc)24,48,72 hours postoperative

Is calculated with routine data. Measurement for overall mobilization (none- passive mobilization, sitting, standing, walking with walking device, walkin free or with crutches)

Analgesic regimenpreop and 0, 6 , 24, 48, 48 hours postoperative

Documentation of analgesic prescriptions and rescue medications during postoperative course

CAS (Cumulated Ambulation Score)24,48,72 hours postoperative

Cumulated Ambulation Score is calculated with routine data. Measurement for ambulation ability

Trial Locations

Locations (1)

University of Marburg Department of Anaesthesia And Intensive Care Medicine

🇩🇪

Marburg, Germany

© Copyright 2025. All Rights Reserved by MedPath